RG
QCOR

Renaissance Group’s QUESTCOR PHARMA INC QCOR Stock Holding History

Renaissance Group’s Portfolio QCOR Stock Details QCOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-3,968
Closed -$230K – 229
2013
Q3 		$230K Buy
+3,968
New +$236K 0.01% 190

Other funds holding QCOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BC
Broadwood Capital New York $1.91B AUM 44.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Renaissance Group's QCOR Position: Q4 2013 in Review

Renaissance Group sold out of QUESTCOR PHARMA INC (QCOR) in Q4 2013, closing a stake of 3,968 shares — an estimated $230K sold.

Renaissance Group first reported a position in QCOR in Q3 2013 and held it in 1 quarter. The position peaked at $230K in Q3 2013. 285 funds tracked by Wall St. Rank hold QCOR as of Q4 2013.

  • Renaissance Group reported no remaining QUESTCOR PHARMA INC position as of Q4 2013 after selling out during the quarter.
  • Renaissance Group sold 3,968 QUESTCOR PHARMA INC shares in Q4 2013, an estimated $230K.
  • Renaissance Group first reported a position in QUESTCOR PHARMA INC in Q3 2013 and held it in 1 quarter.
  • Renaissance Group's QUESTCOR PHARMA INC position peaked at $230K in Q3 2013.
  • 285 funds tracked by Wall St. Rank held QUESTCOR PHARMA INC as of Q4 2013.

Based on Renaissance Group's 13F filing for Q4 2013, filed 12 Feb 2014.